Polymyxin B-34

General Information


DRACP ID  DRACP04271

Peptide Name   Polymyxin B-34

Sequence  XTXXXfLXXT

Sequence Length  10

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  C8

C-terminal Modification  Free

Other Modification  None

Chiral  Mix



Physicochemical Information


Formula  C14H13N3O-1

Absent amino acids  ACDEFGHIKMNPQRSVWY

Common amino acids  X

Mass  102798

Pl  6.11

Basic residues  0

Acidic residues  0

Hydrophobic residues  1

Net charge  0

Boman Index  -22

Hydrophobicity  24

Aliphatic Index  39

Half Life 
  /

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  2

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 26734854

Title  Activity and Predicted Nephrotoxicity of Synthetic peptide Antibiotics Based on Polymyxin B

Doi Not available

Year  2016

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  18778

DRACP is developed by Dr.Zheng's team.